Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Consensus Recommendation of “Buy” by Analysts

Reckitt Benckiser Group plc (OTCMKTS:RBGLYGet Free Report) has been given an average recommendation of “Buy” by the eight analysts that are presently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and four have assigned a strong buy recommendation to the company.

RBGLY has been the topic of a number of recent analyst reports. UBS Group raised Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, December 11th. HSBC raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Friday, October 4th. Finally, Sanford C. Bernstein lowered Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a report on Monday, November 4th.

Read Our Latest Stock Report on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Performance

OTCMKTS:RBGLY opened at $12.03 on Wednesday. Reckitt Benckiser Group has a one year low of $10.24 and a one year high of $15.03. The business’s 50-day simple moving average is $12.22 and its 200 day simple moving average is $11.83. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.